What is the ticker symbol for ImmunityBio, Inc.?

The ticker symbol for ImmunityBio, Inc. is NASDAQ:IBRX

Does ImmunityBio, Inc. pay dividends?

No, ImmunityBio, Inc. does not pay dividends

What sector is ImmunityBio, Inc. in?

ImmunityBio, Inc. is in the Healthcare sector

What industry is ImmunityBio, Inc. in?

ImmunityBio, Inc. is in the Biotechnology industry

What country is ImmunityBio, Inc. based in?

ImmunityBio, Inc. is headquartered in United States

When did ImmunityBio, Inc. go public?

ImmunityBio, Inc. initial public offering (IPO) was on July 28, 2015

Is ImmunityBio, Inc. in the S&P 500?

No, ImmunityBio, Inc. is not included in the S&P 500 index

Is ImmunityBio, Inc. in the NASDAQ 100?

No, ImmunityBio, Inc. is not included in the NASDAQ 100 index

Is ImmunityBio, Inc. in the Dow Jones?

No, ImmunityBio, Inc. is not included in the Dow Jones index

When was ImmunityBio, Inc. last earnings report?

ImmunityBio, Inc.'s most recent earnings report was on August 4, 2026

When does ImmunityBio, Inc. report earnings?

The next expected earnings date for ImmunityBio, Inc. is November 3, 2026

IBRX Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, IBRX price is $8.42, down -8.28% on October 19, 2026
Current Price All-Time High: IBRX price is currently -81.46% below its historical high of $45.42 set on February 22, 2021
Market Cap: IBRX current market cap is $9B, up +277.50% over the past 365 days
Revenue: IBRX current annual revenue is $113.29M, up +668.31% year-over-year
Next Earnings: The next earnings release for IBRX is on November 3, 2026

Profile

Company profile for ImmunityBio, Inc. (IBRX)
Metric	Value
Full Name	ImmunityBio, Inc.
Ticker	NASDAQ: IBRX
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Jul 28, 2015
Indexes	Not included
Website	immunitybio.com
Employees	671

Key Metrics

ImmunityBio, Inc. Key Details
Metric	Value	Date
Price	$8.42	Oct 19, 26
Price, 1D Change	-8.28%	Oct 19, 26
Market Cap	$9B	Oct 19, 26
	-	Oct 19, 26
PE Ratio	-	Oct 19, 26
Beta	1.63	Oct 19, 26
Revenue	$113.29M	Dec 31, 25
Revenue, 1Y Change	+668.31%	Dec 31, 25
EPS	-$0.38	Dec 31, 25
EPS, 1Y Change	+38.28%	Dec 31, 25

Events

ImmunityBio, Inc. Events
Metric	Value	Date
Next Earnings		Nov 3, 26
Last Qtr. Earnings		Aug 4, 26
Last Ann. Earnings		Feb 23, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	NK	Mar 10, 21
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

IBRX Estimates
Metric	Value	Date
EPS	-$0.38	Dec 31, 25
EPS Estimate	-$0.92	N/A
EPS Est. Change	-139.53%	N/A
Revenue	$113.29M	Dec 31, 25
Revenue Estimate	$226.56M	N/A
Revenue Est. Change	+99.98%	N/A
Current Price	$8.42	Oct 19, 26
Price Target	$14.50	-
Price Tgt. Change	+72.21%	-

🔒 Log In To Unlock Full Data

EPS

IBRX EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$0.67	-$0.62	+7.63%
2025	-$0.40	-$0.38	+5.28%
2026	-$0.92	N/A	-139.53%
2027	-$0.07	N/A	+80.81%

Revenue

IBRX revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$21.23M	$14.75M	-30.54%
2025	$112.82M	$113.29M	+0.41%
2026	$226.56M	N/A	+99.98%
2027	$471.90M	N/A	+316.55%

🔒 Log In To Unlock Full Data

Performance

IBRX Performance
Metric	Value	Date
Price, 1Y	+250.83%	Oct 19, 26
Price, 3Y	+570.92%	Oct 19, 26
Market Cap, 1Y	+277.50%	Oct 19, 26
Market Cap, 3Y	+964.94%	Oct 19, 26
Revenue, 1Y	+668.31%	Dec 31, 25
Revenue, 3Y	+47,103.33%	Dec 31, 25
EPS, 1Y	+38.28%	Dec 31, 25
EPS, 3Y	+63.33%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

IBRX Technical Indicators
Metric	Value	Date
Current Price	$8.42	Oct 19, 26
SMA 200	$7.63	Oct 19, 26
SMA 50	$8.58	Oct 19, 26
EMA 200	$7.31	Oct 19, 26
EMA 50	$8.79	Oct 19, 26
MACD	$0.27	Oct 19, 26
Beta	1.63	Oct 19, 26
ATR	$0.74	Oct 19, 26
14-Day RSI	41.84	Oct 19, 26
10-Day Volatility	76.11%	Oct 19, 26

Dividends

IBRX Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Oct 19, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

IBRX Income & Profitability
Metric	Value	Date
Revenue	$113.29M	Dec 31, 25
EPS	-$0.38	Dec 31, 25
Gross Profit	$97.01M	Dec 31, 25
Gross Margin	85.63%	Dec 31, 25
Operating Income	-$256.03M	Dec 31, 25
Operating Margin	-226.00%	Dec 31, 25
Net Income	-$351.47M	Dec 31, 25
Net Margin	-310.25%	Dec 31, 25
EBITDA	-$240.50M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

IBRX Financial Health
Metric	Value	Date
Debt To Equity	-1.69	Dec 31, 25
	5.10	Dec 31, 25
	5.08	Dec 31, 25
	-	Dec 31, 25
	4	Jun 30, 26
	-5.90	Oct 19, 26

Valuations

IBRX Valuations
Metric	Value	Date
PE Ratio	-	Oct 19, 26
	53.83	Oct 19, 26
	-8.53	Oct 19, 26
	-41.65	Oct 19, 26
	-	N/A

Balance Sheet

IBRX Balance Sheet
Metric	Value	Date
Book Value	-$500.47M	Dec 31, 25
	$242.82M	Dec 31, 25
	$501.90M	Dec 31, 25
	$314.88M	Dec 31, 25
	$1.00B	Dec 31, 25
	$61.75M	Dec 31, 25
Total Debt	$844.67M	Dec 31, 25
	$9.29M	Dec 31, 25
	$6.98M	Dec 31, 25

Expenses

IBRX Expenses
Metric	Value	Date
	$464.69M	Dec 31, 25
	$353.04M	Dec 31, 25
	$16.28M	Dec 31, 25
	$0.00	Dec 31, 25
	$15.53M	Dec 31, 25
	$0.00	Dec 31, 25
	-$135.00K	Dec 31, 25

Cash Flow

IBRX Cash Flow
Metric	Value	Date
	-$304.94M	Dec 31, 25
	-$149.80M	Dec 31, 25
	$400.24M	Dec 31, 25
Capex	$4.25M	Dec 31, 25
	-$309.19M	Dec 31, 25

Recent analyst updates

IBRX Recent analyst updates
Metric	Value	Date
Jefferies	→	Oct 15, 26
HC Wainwright & Co.	→	Oct 15, 26
HC Wainwright & Co.	→	Jun 2, 26
BTIG	→	May 21, 26
HC Wainwright & Co.	→	May 20, 26
D. Boral Capital	→	May 5, 26
D. Boral Capital	→	Apr 21, 26
D. Boral Capital	→	Apr 8, 26
D. Boral Capital	→	Mar 26, 26
D. Boral Capital	→	Mar 23, 26

Analyst sentiment

Institutional ownership

Screeners with IBRX

FAQ

What is the ticker symbol for ImmunityBio, Inc.?: The ticker symbol for ImmunityBio, Inc. is NASDAQ:IBRX
Does ImmunityBio, Inc. pay dividends?: No, ImmunityBio, Inc. does not pay dividends
What sector is ImmunityBio, Inc. in?: ImmunityBio, Inc. is in the Healthcare sector
What industry is ImmunityBio, Inc. in?: ImmunityBio, Inc. is in the Biotechnology industry
What country is ImmunityBio, Inc. based in?: ImmunityBio, Inc. is headquartered in United States
When did ImmunityBio, Inc. go public?: ImmunityBio, Inc. initial public offering (IPO) was on July 28, 2015
Is ImmunityBio, Inc. in the S&P 500?: No, ImmunityBio, Inc. is not included in the S&P 500 index
Is ImmunityBio, Inc. in the NASDAQ 100?: No, ImmunityBio, Inc. is not included in the NASDAQ 100 index
Is ImmunityBio, Inc. in the Dow Jones?: No, ImmunityBio, Inc. is not included in the Dow Jones index
When was ImmunityBio, Inc. last earnings report?: ImmunityBio, Inc.'s most recent earnings report was on August 4, 2026
When does ImmunityBio, Inc. report earnings?: The next expected earnings date for ImmunityBio, Inc. is November 3, 2026

Data Sources & References

IBRX Official Website immunitybio.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1326110/000132611026000030/0001326110-26-000030-index.htm
IBRX Profile on Yahoo Finance finance.yahoo.com/quote/IBRX
IBRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ibrx